Keiichi Fukuda

Keiichi Fukuda

Company: Heartseed Inc

Job title: Chief Executive Officer


New Era of Heart Failure Treatment: Regenerative Cell Therapy Using Ventricular Specific Purified Cardiomyocytes 9:00 am

Scalable method to eliminate undifferentiated iPSCs by difference of metabolism between iPSCs and cardiomyocytes Clinical data from FIH study of purified cardiomyocyte spheroids Platform technology to develop high quality iPSC-derived productRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.